ReviewCancers2024
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.
Xinyi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewCancers2024
Xinyi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.